Subscribe To

Price Alert Latest News Economic Calendar News

LTRN / Lantern Pharma to Present at the American Association for Cancer Research (AACR) Annual Meeting

DALLAS--(BUSINESS WIRE)---- $LTRN--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that the Company will present at the American Association for Cancer Research (AACR) Annual Meeting. Read More

Demo Live Account See Partner Details

Content Topics

Lantern

Pharma

Present

American

Association

Cancer

Research

aacr

Annual

Meeting

Stock

LTRN

Posted: Mar 15 2023, 08:00

Author Name: Business Wire

LTRN News

By InvestorPlace
August 28, 2023

3 AI Stocks That Still Trade Under $10 Per Share

The artificial intelligence ( AI ) boom is far from over. For example let's look at Nvidia (NASDAQ: NVDA ), where CEO Jensen Huang still believes his

By Seeking Alpha
August 9, 2023

Lantern Pharma Inc. (LTRN) Q2 2023 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Nicole Leber – Investor Relations

By InvestorPlace
August 9, 2023

3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True

As we forge ahead into the AI era, the top AI penny stocks have become increasingly relevant, emerging as a buzzword among savvy investors. Projected

By InvestorPlace
August 1, 2023

3 AI Stocks to Buy Under $10 in August 2023

The bull market in artificial intelligence is just getting started. In fact, with the boom only set to accelerate, we may be looking at a $1.81 trilli

By Seeking Alpha
May 13, 2023

Lantern Pharma Inc. (LTRN) Q1 2023 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Nicole Leber - Investor Relations Asso

By Seeking Alpha
March 20, 2023

Lantern Pharma Inc. (LTRN) Q4 2022 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN ) Q4 2022 Results Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Nicole Leber - Investor Rel

By Pulse2
March 20, 2023

LTRN Stock: 7.74% Increase After Hours Explanation

The stock price of Lantern Pharma Inc (NASDAQ: LTRN) increased by 7.74% after hours in the most recent trading session. This is why.

By Business Wire
March 15, 2023

Lantern Pharma to Present at the American Association for Cancer Research (AACR) Annual Meeting

DALLAS--(BUSINESS WIRE)---- $LTRN--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® artific

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.